FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I) , in which Ra is H, CH3 or isopropyl, Rb is H, halogen, C1-6alkoxygroup or C1-6alkyl, and or I. R is radical of formula (b) , R4 is 1-pyperasinyl, substituted with CH3 in positions 3 and/or 4, Ra is not H or CH3, when R4 is 4-methyl-1-pyperazinyl; or III. R is remaining part of formula (c) , in which R14 is 1-pyperazinyl, optionally substituted with CH3 in position 3; or 4,7-diase-spiro[2,5]oct-7-yl, R15 is halogen, CF3 or CH3, R15 is not CH3, when R16 stands for CH3, Ra is H or CH3, Rb is H, and R14 is 4-methyl-1-pyperazinyl, and R16 is H, CH3 or CF3, R16 is not H, when R15 is Cl, Ra is H or CH3, Rb is H, and R14 is 4-methyl-1-pyperazinyl, or IV. R is radical of formula (d) , in which R8 is 1-pyperazinyl, 3- methyl-1-pyperazin-l-yl or 4-benzyl-pyperazin-1-yl, or V. R is radical of formula (e) , in which R9 is 4,7-diase-spiro[2,5]oct-7-yl or pyperazin-1-yl, substituted in position 3 with ethyl, or its salt, method of their production, based on them pharmaceutical composition and application for obtaining medication for treatment or prevention of T-lymphocyte and-or "ПКС"-mediated diseases or disorders.
EFFECT: increase of composition and treatment method efficiency.
12 cl, 5 tbl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED N2-(4-AMINO-2-METHOXYPHENYL)-N4-[2-(DIMETHYLPHOSPHORYL)-PHENYL]-5-CHLORO-PYRIMIDINE-2,4-DIAMINES AS MODULATORS OF ALK AND EGFR, APPLICABLE FOR TREATING CANCER | 2015 |
|
RU2607371C1 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
QUINOLINE DERIVATIVES AS SMO INHIBITORS | 2015 |
|
RU2695815C2 |
NEW COMPOUNDS - NEUROKININ 1 RECEPTOR ANTAGONIZER | 2013 |
|
RU2631319C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
ANALOGUES OF 4H-PYRAZOLO[1,5-A]BENZIMIDAZOLE COMPOUNDS AS PARP INHIBITORS | 2015 |
|
RU2672722C2 |
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
DIARYL HYDANTOINS | 2011 |
|
RU2638833C2 |
VASOPRESSIN V RECEPTOR ANTAGONISTS | 2005 |
|
RU2370497C2 |
Authors
Dates
2008-12-10—Published
2003-04-02—Filed